Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

910 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
PD-1 blockade therapy promotes infiltration of tumor-attacking exhausted T cell clonotypes.
Nagasaki J, Inozume T, Sax N, Ariyasu R, Ishikawa M, Yamashita K, Kawazu M, Ueno T, Irie T, Tanji E, Morinaga T, Honobe A, Ohnuma T, Yoshino M, Iwata T, Kawase K, Sasaki K, Hanazawa T, Kochin V, Kawamura T, Matsue H, Hino M, Mano H, Suzuki Y, Nishikawa H, Togashi Y. Nagasaki J, et al. Among authors: yoshino m. Cell Rep. 2022 Feb 1;38(5):110331. doi: 10.1016/j.celrep.2022.110331. Cell Rep. 2022. PMID: 35108529 Free article.
Eradication of intractable malignant ascites by abdominocentesis, reinfusion of concentrated ascites, and adoptive immunotherapy with dendritic cells and activated killer cells in a patient with recurrent lung cancer: a case report.
Kimura H, Iizasa T, Ishikawa A, Yoshino M, Shingyouji M, Kimura M, Hirata T, Odaka A, Matsubayasi K. Kimura H, et al. Among authors: yoshino m. J Med Case Rep. 2008 Dec 4;2:372. doi: 10.1186/1752-1947-2-372. J Med Case Rep. 2008. PMID: 19055844 Free PMC article.
Prospective phase II study of post-surgical adjuvant chemo-immunotherapy using autologous dendritic cells and activated killer cells from tissue culture of tumor-draining lymph nodes in primary lung cancer patients.
Kimura H, Iizasa T, Ishikawa A, Shingyouji M, Yoshino M, Kimura M, Inada Y, Matsubayashi K. Kimura H, et al. Among authors: yoshino m. Anticancer Res. 2008 Mar-Apr;28(2B):1229-38. Anticancer Res. 2008. PMID: 18505060 Free article. Clinical Trial.
Molecular characterization of chronic obstructive pulmonary disease-related non-small cell lung cancer through aberrant methylation and alterations of EGFR signaling.
Suzuki M, Wada H, Yoshino M, Tian L, Shigematsu H, Suzuki H, Alaa M, Tamura H, Fujiwara T, Nagato K, Motohashi S, Moriya Y, Hoshino H, Yoshida S, Shibuya K, Hiroshima K, Nakatani Y, Yoshino I. Suzuki M, et al. Among authors: yoshino i, yoshino m. Ann Surg Oncol. 2010 Mar;17(3):878-88. doi: 10.1245/s10434-009-0739-3. Epub 2009 Oct 16. Ann Surg Oncol. 2010. PMID: 19841986
Prostaglandin E2 receptor 2 overexpression in squamous cell carcinoma of the lung correlates with p16INK4A methylation and an unfavorable prognosis.
Alaa M, Suzuki M, Yoshino M, Tian L, Suzuki H, Nagato K, Fujiwara T, Wada H, Moriya Y, Hoshino H, Motohashi S, Yoshida S, Shibuya K, Hiroshima K, Nakatani Y, Abdrabou A, Elkholy M, Mahfouz T, Yoshino I. Alaa M, et al. Among authors: yoshino i, yoshino m. Int J Oncol. 2009 Mar;34(3):805-12. doi: 10.3892/ijo_00000206. Int J Oncol. 2009. PMID: 19212685
Papillary carcinoma of the thymus gland.
Yoshino M, Hiroshima K, Motohashi S, Shibuya K, Iyoda A, Sekine Y, Fujisawa T. Yoshino M, et al. Ann Thorac Surg. 2005 Aug;80(2):741-2. doi: 10.1016/j.athoracsur.2004.02.018. Ann Thorac Surg. 2005. PMID: 16039252
910 results